CELSIGNIA Trademark

Trademark Overview

On Monday, May 18, 2020, a trademark application was filed for CELSIGNIA with the United States Patent and Trademark Office. The USPTO has given the CELSIGNIA trademark a serial number of 88920922. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 29, 2023. This trademark is owned by Celcuity Inc.. The CELSIGNIA trademark is filed in the Pharmaceutical Products category with the following description:

Medical diagnostic test that employs in vitro assays for analyzing cancer cells to identify specific biological drivers of the cancer; medical cell based assays for testing cancer cells for use in selecting therapeutics in the treatment of cancer
celsignia

General Information

Serial Number88920922
Word MarkCELSIGNIA
Filing DateMonday, May 18, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 29, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 2, 2021

Trademark Statements

Goods and ServicesMedical diagnostic test that employs in vitro assays for analyzing cancer cells to identify specific biological drivers of the cancer; medical cell based assays for testing cancer cells for use in selecting therapeutics in the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 2, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCelcuity Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMinneapolis, MN 55446
Party NameCelcuity Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMinneapolis, MN 55446

Trademark Events

Event DateEvent Description
Tuesday, May 30, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 29, 2023ABANDONMENT - NO USE STATEMENT FILED
Saturday, October 29, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 27, 2022SOU EXTENSION 3 GRANTED
Thursday, October 27, 2022SOU EXTENSION 3 FILED
Thursday, October 27, 2022SOU TEAS EXTENSION RECEIVED
Thursday, April 28, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 26, 2022SOU EXTENSION 2 GRANTED
Tuesday, April 26, 2022SOU EXTENSION 2 FILED
Tuesday, April 26, 2022SOU TEAS EXTENSION RECEIVED
Friday, October 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 27, 2021SOU EXTENSION 1 GRANTED
Wednesday, October 27, 2021SOU EXTENSION 1 FILED
Wednesday, October 27, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, April 27, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 2, 2021PUBLISHED FOR OPPOSITION
Wednesday, February 10, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 25, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 13, 2021EXAMINER'S AMENDMENT ENTERED
Wednesday, January 13, 2021ASSIGNED TO LIE
Wednesday, January 13, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, January 13, 2021EXAMINERS AMENDMENT E-MAILED
Wednesday, January 13, 2021EXAMINERS AMENDMENT -WRITTEN
Monday, December 14, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 14, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 14, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 21, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, August 21, 2020NON-FINAL ACTION E-MAILED
Friday, August 21, 2020NON-FINAL ACTION WRITTEN
Monday, August 17, 2020ASSIGNED TO EXAMINER
Tuesday, June 2, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 21, 2020NEW APPLICATION ENTERED

Related Keywords

celsignia cancer cells medical assays treatment cell therapeutics selecting drivers based